[HTML] nih.gov

Coagulopathy of coronavirus disease 2019

T Iba, JH Levy, M Levi, JM Connors… - Critical care …, 2020 - journals.lww.com
Objectives: Recent studies have reported a high prevalence of thrombotic events in
coronavirus disease 2019. However, the significance of thromboembolic complications has …
被引用次数：637 相关文章 所有 10 个版本
[HTML] ahajournals.orgFull View

Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management

L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - Am Heart Assoc
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …
被引用次数：182 相关文章 所有 11 个版本
[HTML] nih.gov

Incidence of venous thromboembolism in critically ill coronavirus disease 2019 patients receiving prophylactic anticoagulation

RA Trigonis, DB Holt, R Yuan, AA Siddiqui… - Critical Care …, 2020 - journals.lww.com
Objectives: One of the defining features of the novel coronavirus disease 2019 infection has
been high rates of venous thromboses. The present study aimed to describe the prevalence …
被引用次数：65 相关文章 所有 10 个版本
[HTML] nih.gov

Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection

AT Obi, GD Barnes, LM Napolitano, PK Henke… - Journal of Vascular …, 2021 - Elsevier
Objective Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus confers a risk of significant coagulopathy, with the resulting development of venous …
被引用次数：78 相关文章 所有 8 个版本
[HTML] nih.gov

Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019

TK Maatman, F Jalali, C Feizpour… - Critical care …, 2020 - journals.lww.com
Objectives: The aim of this study was to determine the frequency of venous
thromboembolism in critically ill coronavirus disease 2019 patients and associate a degree …
被引用次数：197 相关文章 所有 12 个版本
[HTML] sciencedirect.comFull View

[HTML][HTML] A proposal for staging COVID‐19 coagulopathy

J Thachil, M Cushman, A Srivastava… - Research and practice …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID‐19) is associated with significant
hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with …
被引用次数：121 相关文章 所有 12 个版本
[HTML] nih.gov

COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation

JK Salabei, TJ Fishman, ZT Asnake, A Ali, UG Iyer - Heart & Lung, 2021 - Elsevier
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …
被引用次数：71 相关文章 所有 8 个版本
[HTML] springer.com

[HTML][HTML] Management of thrombotic complications in COVID-19: an update

A Hajra, SV Mathai, S Ball, D Bandyopadhyay… - Drugs, 2020 - Springer
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …
被引用次数：71 相关文章 所有 15 个版本
[HTML] mdpi.com

[HTML][HTML] Coagulative disorders in critically ill COVID-19 patients with acute distress respiratory syndrome: a critical review

C Robba, D Battaglini, L Ball, A Valbusa, I Porto… - Journal of Clinical …, 2021 - mdpi.com
In critically ill patients with acute respiratory distress syndrome (ARDS) coronavirus disease
2019 (COVID-19), a high incidence of thromboembolic and hemorrhagic events is reported …
被引用次数：39 相关文章 所有 9 个版本
[HTML] springer.com

[HTML][HTML] Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review

WJ Jenner, R Kanji, S Mirsadraee, YX Gue… - Journal of thrombosis …, 2021 - Springer
A prothrombotic state is reported with severe COVID-19 infection, which can manifest in
venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease …
被引用次数：94 相关文章 所有 14 个版本